P06276 |
CHLE_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P06276 |
CHLE_HUMAN |
Tonus and reflex abnormality [ICD-11: MB47] |
P06276 |
CHLE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P06276 |
CHLE_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P06276 |
CHLE_HUMAN |
Eexposure to noxious substances harmful effect [ICD-11: NE61] |
P06276 |
CHLE_HUMAN |
Toxicity [ICD-11: N.A.] |
P06276 |
CHLE_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P22303 |
ACES_HUMAN |
Glaucoma [ICD-11: 9C61] |
P22303 |
ACES_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P22303 |
ACES_HUMAN |
Oesophageal/gastroduodenal disorder [ICD-11: DD90] |
P22303 |
ACES_HUMAN |
Pediculosis [ICD-11: 1G00] |
P22303 |
ACES_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P22303 |
ACES_HUMAN |
Parasitic worm infestation [ICD-11: 1F90] |
P22303 |
ACES_HUMAN |
Dementia [ICD-11: 6D80-6D8Z] |
P22303 |
ACES_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P22303 |
ACES_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P22303 |
ACES_HUMAN |
Substance abuse [ICD-11: 6C40] |
P22303 |
ACES_HUMAN |
Lips/oral mucosa miscellaneous disorder [ICD-11: DA02] |
P22303 |
ACES_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P22303 |
ACES_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
P22303 |
ACES_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P10275 |
ANDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10275 |
ANDR_HUMAN |
Alcoholic liver disease [ICD-11: DB94] |
P10275 |
ANDR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 |
ANDR_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P10275 |
ANDR_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P10275 |
ANDR_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P10275 |
ANDR_HUMAN |
Hypo-osmolality/hyponatraemia [ICD-11: 5C72] |
P10275 |
ANDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P10275 |
ANDR_HUMAN |
Mammary tumour [ICD-11: 2C60-2C6Z] |
P10275 |
ANDR_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P10275 |
ANDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10275 |
ANDR_HUMAN |
Testicular dysfunction [ICD-11: 5A81] |
P10275 |
ANDR_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P10275 |
ANDR_HUMAN |
Alopecia [ICD-11: ED70] |
P10275 |
ANDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P10275 |
ANDR_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P10275 |
ANDR_HUMAN |
Contraceptive management [ICD-11: QA21] |
P10275 |
ANDR_HUMAN |
Heart failure [ICD-11: BD10-BD1Z] |
P10275 |
ANDR_HUMAN |
Muscle disorder [ICD-11: FB32-FB3Z] |
P10275 |
ANDR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P10275 |
ANDR_HUMAN |
Cystic fibrosis [ICD-11: CA25] |
P10275 |
ANDR_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P10275 |
ANDR_HUMAN |
Cachexia [ICD-11: MG20] |
P10275 |
ANDR_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P10275 |
ANDR_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P10275 |
ANDR_HUMAN |
Oesophagitis [ICD-11: DA24] |
P10275 |
ANDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10275 |
ANDR_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P10275 |
ANDR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 |
ANDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10275 |
ANDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |